Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS withdrawal · 2026-04-09

Clinical Trial Update: Vatiquinone Expanded Access Protocol

View source ↗

Summary

The expanded access protocol for vatiquinone in mitochondrial disease is no longer available.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Vatiquinone

Snippet

Sponsor: Medical University of South Carolina | Conditions: Mitochondrial Disease | Status: NO_LONGER_AVAILABLE